Objective: To evaluate the efficacy of AGEs Blocker™ in improving skin health through its anti-glycation and anti-aging effects.

Study Design:

Participants: 96 women aged 30–60 with visible wrinkles and dry skin.

Dosage: 500 mg daily or placebo

Study Type: Randomized, double-blind, placebo-controlled clinical trial.

Duration: 3 months.

Results:

Significantly inhibited the formation of AGEs

Significantly improved skin elasticity, dermal density, hydration, and radiance. Significantly reduced the appearance of dark spots.